CIENCIASMEDICASNEWS: Monoclonal Antibody Prevents Malaria in U.S. Adults, NIH Trial Shows | NIH: National Institute of Allergy and Infectious Diseases

jueves, 4 de agosto de 2022

Monoclonal Antibody Prevents Malaria in U.S. Adults, NIH Trial Shows | NIH: National Institute of Allergy and Infectious Diseases

Monoclonal Antibody Prevents Malaria in U.S. Adults, NIH Trial Shows | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)